Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 3Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Leukemia 10Breast Neoplasms 10Melanoma 9Congenital Abnormalities 9Leukemia, Myeloid, Acute 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Multiple Myeloma 6Lymphoma, Follicular 6Lymphoma, Non-Hodgkin 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma 5Leukemia, Lymphocytic, Chronic, B-Cell 5Burkitt Lymphoma 5Unspecified Adult Solid Tumor, Protocol Specific 4Neuroblastoma 4Neoplasms, Plasma Cell 4Myeloproliferative Disorders 4Myelodysplastic Syndromes 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Accelerated Phase 4Head and Neck Neoplasms 4Carcinoma, Ovarian Epithelial 4Squamous Cell Carcinoma of Head and Neck 3Primary Myelofibrosis 3Pdgfra-Associated Chronic Eosinophilic Leukemia 3Pancreatic Neoplasms 3

Interventions

Sunitinib 86Sorafenib 60Everolimus 47pazopanib 46Bevacizumab 46Nivolumab 44pembrolizumab 37aldesleukin 29Interferon-alpha 26Axitinib 24temsirolimus 23cabozantinib 20Interleukin-2 19Ipilimumab 16Interferon alpha-2 15Cyclophosphamide 15fludarabine phosphate 14Gemcitabine 14Peripheral Blood Stem Cell Transplantation 11Sirolimus 10Paclitaxel 10Erlotinib Hydrochloride 10avelumab 8Radiosurgery 8Docetaxel 8Cyclosporine 8Capecitabine 8tremelimumab 7lenvatinib 7Mycophenolic Acid 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Carcinoma, Renal Cell × Immunologic Techniques × Clear all
NCT01157091 2022-06-08

Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer

City of Hope Medical Center

Phase 2 Completed
28 enrolled 10 charts
Genitourinary

Carcinoma, Renal Cell

NCT00900276 2018-07-05

Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants

Wake Forest University Health Sciences

Completed
5 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Urethral Neoplasms

NCT01158534 2012-08-07

Celecoxib and Recombinant Interferon Alfa-2b in Metastatic Kidney Cancer Who Have Undergone Surgery

Case Comprehensive Cancer Center

Phase 2 Completed
17 enrolled 9 charts
Genitourinary

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡